CMO™ is All Natural and 100% Safe for People and Pets
CMO™ Highlights
|
|
"CMO...actually cured mine, and has helped another daughter with RA" |
"CMO is the Golden Egg of my Practice." There hasn't really been anyone it hasn't helped. - Dr. Christine Doherty N.D. Milford NH |
|
CMO™ has been found through clinical studies and client testimonies to benefit many with autoimmune diseases such as Osteoarthritis, Rheumatoid Arthritis, Fibromyalgia, Lupus, Crohn’s disease, Sjögren’s Syndrome, Solomons Syndrome,Multiple Sclerosis, Chronic Vulvar Pain and more. |
CMO™ is part of the Pain Project Protocol developed by biomedical research scientist Clive C. Solomons, Ph.D. CMO™ inhibits the breakdown of hyaluronic acid, a component of healthy functioning connective tissue. We are endorsed by The VP Foundation as a trusted CMO™ distributor |
Everyday Low Prices
|
|
There are obstacles to overcome in the part of the user. The consumption of caffeine, chocolate and alcoholic beverages during the treatment block our product. Also the presence of hard drugs such as methotrexate which act as immune suppressants have a similar effect of blockade. Cortisones block partially. Please see the Dosing/Guidelines tab for further information.
|
- CMO™ is revolutionary dietary supplement derived from beef tallow. This process provides a naturally associated group of fatty acids. CMO™ is a unique, concentrated, 100% natural, pure nutritional "food".
- CMO™ is not an immunosuppressant, it's not an immunostimulant and it's not a pharmaceutical. It is a naturally derived substance that has received the highest safety level attainable by certified independent laboratory testing.
- CMO™ is a general remedial immunomodulator that acts upon the memory T-cells which control the autoimmune processes within our bodies. Works on all types of Arthritis *except Gout
- CMO™ acts only upon memory T-cells and does not inhibit the activities of any of the several other types of T-cells that are responsible for combating infective microorganisms or invading substances.
- Unlike the immunosuppressants commonly used to try to temporarily control the symptoms of autoimmune diseases, CMO™ does not leave the body vulnerable to attack by disease-causing agents.
- CMO™ is equally effective and 100% safe on animals.
 Numerous Books have been written documenting the positive effects of CMO on Arthritis
|
The CMO™ discovery
In 1971, the predecessor of CMO™ capsules, was first discovered by a researcher at the National Institutes of Health. That predecessor was cetyl myristoleate. The researcher was unable to get his project funded and slowly carried on at his own expense. Eventually he discovered that when this substance was injected near the joints of lab animals it brought amazing results. Many years later he experienced the same benefit on his body. After his doctor could provide no further relief through conventional medicine, he successfully injected himself cetylmyristoleate on the knees. His doctor was so amazed at the beneficial results, he urged him to publish a report.
In March of 1994, that report about injectable cetyl myristoleate was published in The Journal of Pharmaceutical Sciences. In the report, the researcher expressed his hope that other studies would be conducted, "particularly, more extensive tests of cetyl myristoleate analogues.”In late 1994, the International Immunological Center of The San Diego Clinic research staff did exactly what that researcher had hoped for. They developed an orally administered nutritional supplement. This dietary supplement is an analogue called CMO™, a trade name for cerasomal-cis-9-cetylmyristoleate. The San Diego Clinic did the first clinical study on CMO™, which study demonstrated CMO™ to be an outstanding product.
In December 1995, CMO™ was introduced in Nevada to the medical community at the National Medical Conference on Aging. Five doctors afflicted with a variety of conditions tried CMO™. All five doctors responded well within three days. CMO™ became star of the conference resulting ultimately in hundreds of doctors using CMO™ for their patients.In February 1996, after successful reports from the medical community, CMO™ became available to the public. Beneficial effects of CMO™ inspired several books about the subject. Dr Sands had numerous radio interviews and the attention of newspapers and magazines.
In March of 1994, that report about injectable cetyl myristoleate was published in The Journal of Pharmaceutical Sciences. In the report, the researcher expressed his hope that other studies would be conducted, "particularly, more extensive tests of cetyl myristoleate analogues.”In late 1994, the International Immunological Center of The San Diego Clinic research staff did exactly what that researcher had hoped for. They developed an orally administered nutritional supplement. This dietary supplement is an analogue called CMO™, a trade name for cerasomal-cis-9-cetylmyristoleate. The San Diego Clinic did the first clinical study on CMO™, which study demonstrated CMO™ to be an outstanding product.
In December 1995, CMO™ was introduced in Nevada to the medical community at the National Medical Conference on Aging. Five doctors afflicted with a variety of conditions tried CMO™. All five doctors responded well within three days. CMO™ became star of the conference resulting ultimately in hundreds of doctors using CMO™ for their patients.In February 1996, after successful reports from the medical community, CMO™ became available to the public. Beneficial effects of CMO™ inspired several books about the subject. Dr Sands had numerous radio interviews and the attention of newspapers and magazines.
|
We guarantee the authenticity of our CMO™ product. Our CMO™ is manufactured by the family of Dr Len Sands and is the exact formula used in his clinical trials.
|
Click for info